Desloratadine |
Clarinex |
Desloratadine Systematic (IUPAC) name 8-chloro-6,11-dihydro-11-(4-piperdinylidene)- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine Identifiers CAS number 100643-71-8 ATC code R06AX27 PubChem 124087 DrugBank APRD00324 Chemical data Formula C19H19ClN2 Mol. weight 310.82 Pharmacokinetic data Bioavailability rapidly absorbed Protein binding 85% Metabolism Liver Half life 50 hours Excretion 40% as conjugated metabolites into urine similar amount into the feces ...
Wikipedia - [full article]
Desloratadine Clinical Trials
- Airway Responses to Montelukast and Desloratadine.
ClinicalTrials.gov Identifier: NCT00424580 - Active, not recruiting
Asthma
- Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684AM1)
ClinicalTrials.gov Identifier: NCT00405964 - Recruiting
Allergic Rhinitis
- The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
ClinicalTrials.gov Identifier: NCT00346606 - Recruiting
Chronic Idiopathic Urticaria; Urticaria
- Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683AM1)
ClinicalTrials.gov Identifier: NCT00406783 - Recruiting
Rhinitis, Allergic, Seasonal; Rhinitis, Allergic, Perennial
- The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (Study P04441)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00359138 - Completed
Hypersensitivity
- A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-Induced Ocular Signs and Symptoms (Study P04209)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00311844 - Completed
Conjunctivitis, Allergic
- LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)
ClinicalTrials.gov Identifier: NCT00160589 - Completed
Rhinitis, Allergic, Perennial

Not Signed In -


